Name of Information Collection: NASA Software Release Request System, 56474-56475 [2019-23020]

Download as PDF 56474 Federal Register / Vol. 84, No. 204 / Tuesday, October 22, 2019 / Notices preliminarily determined meets the requirements of the Criteria. The following Plans are available for review: • City of Tracy. • Clear Creek Community Services District. • Sacramento County Water Agency. • Westlands Water District. We invite the public to comment on our preliminary (i.e., draft) determination of Plan adequacy. A copy of these Plans will be available for review at Reclamation’s Mid-Pacific Regional Office, 2800 Cottage Way, CGB–410, Sacramento, CA 95825. If you wish to review a copy of these Plans or to receive an electronic copy via email, please contact Ms. Stemen or visit https://www.usbr.gov/ mp/watershare/wcp.html. Dated: October 16, 2019. Richard Woodley, Regional Resources Manager, Mid-Pacific Region, Bureau of Reclamation. [FR Doc. 2019–22958 Filed 10–21–19; 8:45 am] BILLING CODE 4332–90–P DEPARTMENT OF JUSTICE Drug Enforcement Administration In accordance with 21 CFR 1301.33(a), this is notice that on September 10, 2019, Johnson Matthey, Inc., 2003 Nolte Drive, West Deptford, New Jersey 08066–1743 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: SUPPLEMENTARY INFORMATION: [Docket No. DEA–524] Bulk Manufacturer of Controlled Substances Application: Johnson Matthey, Inc. ACTION: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before December 23, 2019. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. DATES: Notice of application. Controlled substance Drug code Gamma Hydroxybutyric Acid ................................................................................................................................... Marihuana ................................................................................................................................................................ Tetrahydrocannabinols ............................................................................................................................................ Dihydromorphine ..................................................................................................................................................... Difenoxin .................................................................................................................................................................. Amphetamine .......................................................................................................................................................... Methamphetamine ................................................................................................................................................... Lisdexamfetamine ................................................................................................................................................... Methylphenidate ...................................................................................................................................................... Nabilone .................................................................................................................................................................. Cocaine ................................................................................................................................................................... Codeine ................................................................................................................................................................... Dihydrocodeine ........................................................................................................................................................ Oxycodone .............................................................................................................................................................. Hydromorphone ....................................................................................................................................................... Diphenoxylate .......................................................................................................................................................... Ecgonine .................................................................................................................................................................. Hydrocodone ........................................................................................................................................................... Levorphanol ............................................................................................................................................................. Meperidine ............................................................................................................................................................... Methadone ............................................................................................................................................................... Methadone intermediate .......................................................................................................................................... Morphine .................................................................................................................................................................. Thebaine .................................................................................................................................................................. Opium tincture ......................................................................................................................................................... Oxymorphone .......................................................................................................................................................... Noroxymorphone ..................................................................................................................................................... Alfentanil .................................................................................................................................................................. Remifentanil ............................................................................................................................................................. Sufentanil ................................................................................................................................................................. Tapentadol ............................................................................................................................................................... Fentanyl ................................................................................................................................................................... The company plans to bulk manufacture the listed controlled substances for internal use as intermediates or for sale to its customers. In reference to drug codes 7360 (marihuana), and 7370 (tetrahydrocannabinols), the company plans to bulk manufacture these drugs as synthetic. No other activities for these drug codes are authorized for this registration. Dated: October 9, 2019. William T. McDermott, Acting Assistant Administrator. 2010 7360 7370 9145 9168 1100 1105 1205 1724 7379 9041 9050 9120 9143 9150 9170 9180 9193 9220 9230 9250 9254 9300 9333 9630 9652 9668 9737 9739 9740 9780 9801 Schedule I I I I I II II II II II II II II II II II II II II II II II II II II II II II II II II II NATIONAL AERONAUTICS AND SPACE ADMINISTRATION [Notice: (19–070)] [FR Doc. 2019–23012 Filed 10–21–19; 8:45 am] Name of Information Collection: NASA Software Release Request System BILLING CODE 4410–09–P National Aeronautics and Space Administration (NASA). ACTION: Notice of information collection—new information collection. AGENCY: The National Aeronautics and Space Administration, as part of its SUMMARY: VerDate Sep<11>2014 17:02 Oct 21, 2019 Jkt 250001 PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 E:\FR\FM\22OCN1.SGM 22OCN1 Federal Register / Vol. 84, No. 204 / Tuesday, October 22, 2019 / Notices continuing effort to reduce paperwork and respondent burden, invites the general public and other Federal agencies to take this opportunity to comment on proposed and/or continuing information collections. DATES: Comments are due by December 23, 2019. ADDRESSES: All comments should be addressed to Claire Little, National Aeronautics and Space Administration, 300 E Street SW, Washington, DC 20546–0001. FOR FURTHER INFORMATION CONTACT: Requests for additional information or copies of the information collection instrument(s) and instructions should be directed to Claire Little, NASA Clearance Officer, NASA Headquarters, 300 E Street SW, JF0000, Washington, DC 20546 or email claire.a.little@ nasa.gov. SUPPLEMENTARY INFORMATION: I. Abstract NASA Software Release Request System (SRRS) is a workflow tool that allows Agency Software Release Authorities (SRAs) to easily develop and route software release documents, such as the Software Release Request Authorization (SRRA) and Section 508 Compliance Matrix in an automated fashion. SRAs have the added ability to perform parallel routing, including the use of time-based email reminders, tracking and reporting progress on the processing of the software release requests so they can effectively manage this process at their respective centers. Software owners/developers can submit the Software Release Requests or view their submitted Software Release Requests that may need their attention. II. Methods of Collection Web based—only accessible via NASA’s internal network (e.g., on site or remotely via a NASA issued VPN) III. Data Title: NASA Software Release Request System. OMB Number: 2700–xxxx. Type of review: New Information Collection. Affected Public: NASA Funded Contractors and Government Employees. Average Expected Annual Number of Activities: On average 126 software packages are released per year. Average number of Respondents per Activity: At least one respondent will complete the form per activity (software release) which will result in approximately 126 respondents. Annual Responses: 126. VerDate Sep<11>2014 17:02 Oct 21, 2019 Jkt 250001 Frequency of Responses: As needed. Average minutes per Response: 240 minutes. Burden Hours: 504. IV. Request for Comments Comments are invited on: (1) Whether the proposed collection of information is necessary for the proper performance of the functions of NASA, including whether the information collected has practical utility; (2) the accuracy of NASA’s estimate of the burden (including hours and cost) of the proposed collection of information; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) ways to minimize the burden of the collection of information on respondents, including automated collection techniques or the use of other forms of information technology. Comments submitted in response to this notice will be summarized and included in the request for OMB approval of this information collection. They will also become a matter of public record. Cheryl Parker, Federal Liaison Officer. [FR Doc. 2019–23020 Filed 10–21–19; 8:45 am] BILLING CODE 7510–13–P NATIONAL ARCHIVES AND RECORDS ADMINISTRATION [FDMS docket: NARA–19–0015; Agency number: NARA–2020–005] Records Schedules; Availability and Request for Comments National Archives and Records Administration (NARA). ACTION: Notice of availability of proposed records schedules; request for comments AGENCY: The National Archives and Records Administration (NARA) publishes notice of certain Federal agency requests for records disposition authority (records schedules). We publish notice in the Federal Register and on regulations.gov for records schedules in which agencies propose to dispose of records they no longer need to conduct agency business. We invite public comments on such records schedules. DATES: NARA must receive comments by December 6, 2019. ADDRESSES: You may submit comments by either of the following methods. You must cite the control number, which appears on the records schedule in parentheses after the name of the agency that submitted the schedule. SUMMARY: PO 00000 Frm 00065 Fmt 4703 Sfmt 4703 56475 • Federal eRulemaking Portal: http:// www.regulations.gov. • Mail: Records Appraisal and Agency Assistance (ACR); National Archives and Records Administration; 8601 Adelphi Road; College Park, MD 20740–6001. FOR FURTHER INFORMATION CONTACT: Records Management Operations by email at request.schedule@nara.gov, by mail at the address above, or by phone at 301–837–1799. SUPPLEMENTARY INFORMATION: Public Comment Procedures We are publishing notice of records schedules in which agencies propose to dispose of records they no longer need to conduct agency business. We invite public comments on these records schedules, as required by 44 U.S.C. 3303a(a), and list the schedules at the end of this notice by agency and subdivision requesting disposition authority. In addition, this notice lists the organizational unit(s) accumulating the records or states that the schedule has agency-wide applicability. It also provides the control number assigned to each schedule, which you will need if you submit comments on that schedule. We have uploaded the records schedules and accompanying appraisal memoranda to the regulations.gov docket for this notice as ‘‘other’’ documents. Each records schedule contains a full description of the records at the file unit level as well as their proposed disposition. The appraisal memorandum for the schedule includes information about the records. We will post comments, including any personal information and attachments, to the public docket unchanged. Because comments are public, you are responsible for ensuring that you do not include any confidential or other information that you or a third party may not wish to be publicly posted. If you want to submit a comment with confidential information or cannot otherwise use the regulations.gov portal, you may contact request.schedule@nara.gov for instructions on submitting your comment. We will consider all comments submitted by the posted deadline and consult as needed with the Federal agency seeking the disposition authority. After considering comments, we will post on regulations.gov a ‘‘Consolidated Reply’’ summarizing the comments, responding to them, and noting any changes we have made to the proposed records schedule. We will then send the schedule for final E:\FR\FM\22OCN1.SGM 22OCN1

Agencies

[Federal Register Volume 84, Number 204 (Tuesday, October 22, 2019)]
[Notices]
[Pages 56474-56475]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-23020]


=======================================================================
-----------------------------------------------------------------------

NATIONAL AERONAUTICS AND SPACE ADMINISTRATION

[Notice: (19-070)]


Name of Information Collection: NASA Software Release Request 
System

AGENCY: National Aeronautics and Space Administration (NASA).

ACTION: Notice of information collection--new information collection.

-----------------------------------------------------------------------

SUMMARY: The National Aeronautics and Space Administration, as part of 
its

[[Page 56475]]

continuing effort to reduce paperwork and respondent burden, invites 
the general public and other Federal agencies to take this opportunity 
to comment on proposed and/or continuing information collections.

DATES: Comments are due by December 23, 2019.

ADDRESSES: All comments should be addressed to Claire Little, National 
Aeronautics and Space Administration, 300 E Street SW, Washington, DC 
20546-0001.

FOR FURTHER INFORMATION CONTACT: Requests for additional information or 
copies of the information collection instrument(s) and instructions 
should be directed to Claire Little, NASA Clearance Officer, NASA 
Headquarters, 300 E Street SW, JF0000, Washington, DC 20546 or email 
[email protected].

SUPPLEMENTARY INFORMATION: 

I. Abstract

    NASA Software Release Request System (SRRS) is a workflow tool that 
allows Agency Software Release Authorities (SRAs) to easily develop and 
route software release documents, such as the Software Release Request 
Authorization (SRRA) and Section 508 Compliance Matrix in an automated 
fashion. SRAs have the added ability to perform parallel routing, 
including the use of time-based email reminders, tracking and reporting 
progress on the processing of the software release requests so they can 
effectively manage this process at their respective centers. Software 
owners/developers can submit the Software Release Requests or view 
their submitted Software Release Requests that may need their 
attention.

II. Methods of Collection

    Web based--only accessible via NASA's internal network (e.g., on 
site or remotely via a NASA issued VPN)

III. Data

    Title: NASA Software Release Request System.
    OMB Number: 2700-xxxx.
    Type of review: New Information Collection.
    Affected Public: NASA Funded Contractors and Government Employees.
    Average Expected Annual Number of Activities: On average 126 
software packages are released per year.
    Average number of Respondents per Activity: At least one respondent 
will complete the form per activity (software release) which will 
result in approximately 126 respondents.
    Annual Responses: 126.
    Frequency of Responses: As needed.
    Average minutes per Response: 240 minutes.
    Burden Hours: 504.

IV. Request for Comments

    Comments are invited on: (1) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
NASA, including whether the information collected has practical 
utility; (2) the accuracy of NASA's estimate of the burden (including 
hours and cost) of the proposed collection of information; (3) ways to 
enhance the quality, utility, and clarity of the information to be 
collected; and (4) ways to minimize the burden of the collection of 
information on respondents, including automated collection techniques 
or the use of other forms of information technology.
    Comments submitted in response to this notice will be summarized 
and included in the request for OMB approval of this information 
collection. They will also become a matter of public record.

Cheryl Parker,
Federal Liaison Officer.
[FR Doc. 2019-23020 Filed 10-21-19; 8:45 am]
 BILLING CODE 7510-13-P